Page last updated: 2024-08-26

cv 6504 and Bright Disease

cv 6504 has been researched along with Bright Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Nishikawa, K; Ohkawa, S; Shibouta, Y; Terao, S; Terashita, Z	1

Other Studies

1 other study(ies) available for cv 6504 and Bright Disease

Article	Year
Synthesis and biological evaluation of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4-benzoquinone (CV-6504), a dual inhibitor of TXA2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species (AOS). Advances in prostaglandin, thromboxane, and leukotriene research, 1991, Volume: 21A Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antioxidants; Benzoquinones; Drug Design; Drug Evaluation, Preclinical; Free Radicals; Glomerulonephritis; Humans; Leukotriene B4; Lipoxygenase Inhibitors; Molecular Structure; Oxygen; Puromycin Aminonucleoside; Rats; Structure-Activity Relationship; Thromboxane B2; Thromboxane-A Synthase	1991

Article

Year

Synthesis and biological evaluation of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4-benzoquinone (CV-6504), a dual inhibitor of TXA2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species (AOS).

Advances in prostaglandin, thromboxane, and leukotriene research, 1991, Volume: 21A

Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antioxidants; Benzoquinones; Drug Design; Drug Evaluation, Preclinical; Free Radicals; Glomerulonephritis; Humans; Leukotriene B4; Lipoxygenase Inhibitors; Molecular Structure; Oxygen; Puromycin Aminonucleoside; Rats; Structure-Activity Relationship; Thromboxane B2; Thromboxane-A Synthase

1991